Endowed Chair Assistant Professor, Molecular Biology and Pathogenesis of Gastroenterology, Nagoya University Graduate School of Medicine

2010.1 - 2010.12

Researcher, Nagoya University Graduate School of Medicine

2009.10 - 2009.12

Postdoctoral Fellow, The University of Texas MD Anderson Cancer Center

2008.4 - 2009.9

Research Associate, Nagoya National Hospital

2005.7 - 2008.3

Nagoya University Hospital

2004.4 - 2005.6

Nagoya National Hospital

1998.7 - 2000.9

Aichi Saiseikai Hospital

1997.4 - 1998.6

Mitsui Memorial Hospital

1992.5 - 1997.3

Japan Gastroenterological Endoscopy Society

The Japanese Society of Clinical Pharmacology and Therapeutics

Japanese Cancer Association

Japan Society of Clinical Oncology

Japanese Society of Palliative Medicine

The Japanese Society of Gastroenterological Cancer Screening

Japanese Society for Clinical Nutrition and Metabolism

Alteration of gene expression and DNA methylation in drug-resistant gastric cancer Reviewed

Osamu Maeda, Takafumi Ando, Naoki Ohmiya, Kazuhiro Ishiguro, Osamu Watanabe, Ryoji Miyahara, Yoko Hibi, Taku Nagai, Kiyofumi Yamada, Hidemi Goto

Oncology Reports   Vol. 31   page： 1883-1890   2014

Enhancement of GLI1-transcriptional activity by beta-catenin in human cancer cells Reviewed

Osamu Maeda, Masashi Kondo, Takayoshi Fujita, Noriyasu Usami, Takayuki Fukui, Kaoru Shimokata, Takafumi Ando, Hidemi Goto, Yoshitaka Sekido

Oncology Reports   Vol. 16 ( 1 ) page： 91-96   2006.7

Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line Reviewed

Osamu Maeda, Noriyasu Usami, Masashi Kondo, Masahide Takahashi, Hidemi Goto, Kaoru Shimokata, Kazuo Kusugami, Yoshitaka Sekido

Oncogene   Vol. 23   page： 964-972   2004

Chemotherapy for biliary tract cancer: real-world experience in a single institute Reviewed

Maeda, O; Ebata, T; Shimokata, T; Matsuoka, A; Inada-Inoue, M; Morita, S; Takano, Y; Urakawa, H; Miyai, Y; Sugishita, M; Mitsuma, A; Ando, M; Mizuno, T; Nagino, M; Ando, Y

NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 82 ( 4 ) page： 725 - 733   2020.11

Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review Reviewed

Maeda, O; Ohka, F; Maesawa, S; Matsuoka, A; Shimokata, T; Mitsuma, A; Urakawa, H; Nakamura, S; Shimoyamas, Y; Nakaguro, SM; Wakabayashi, T; Ando, Y

NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 82 ( 4 ) page： 631 - 644   2020.11

5-FU, Irinotecan, Nab-Paclitaxel in Gastrointestinal Cancers-Letter Reviewed

Maeda, O; Shimokata, T; Ando, Y

CLINICAL CANCER RESEARCH   Vol. 26 ( 14 ) page： 3889 - 3889   2020.7

Alterations in gene expression and DNA methylation profiles in gastric cancer cells obtained from ascitic fluids collected before and after chemotherapy. Reviewed

Maeda O, Matsuoka A, Furukawa K, Miyahara R, Hirooka Y, Ando Y

Molecular and clinical oncology   Vol. 11 ( 1 ) page： 91 - 98   2019.7

Cabozantinib in Hepatocellular Carcinoma

Maeda Osamu, Ando Yuichi

NEW ENGLAND JOURNAL OF MEDICINE   Vol. 379 ( 14 ) page： 1384 - 1384   2018.10

Nivolumab for the treatment of malignant melanoma in a patient with pre-existing myasthenia gravis Reviewed

Osamu Maeda, Kenji Yokota, Naoki Atsuta, Masahisa Katsuno, Masashi Akiyama, Yuichi Ando

Nagoya Journal of Medical Science   Vol. 78 ( 1 ) page： 119-122   2016.2

Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancer Reviewed

Osamu Maeda, Takafumi Ando, Kazuhiro Ishiguro, Osamu Watanabe, Ryoji Miyahara, Masanao Nakamura, Kohei Funasaka, Kazuhiro Furukawa, Yuichi Ando, Hidemi Goto

Molecular and Clinical Oncology   Vol. 2 ( 6 ) page： 1103-1106   2014.11

A patient with esophageal cancer with bone metastasis who achieved pain relief with repetitive administration of strontium-89 chloride Reviewed

Osamu Maeda, Takafumi Ando, Kazuhiro Ishiguro, Osamu Watanabe, Ryoji Miyahara, Masanao Nakamura, Kohei Funasaka, Kazuhiro Furukawa, Yuichi Ando, Katsuhiko Kato, Hidemi Goto

Clinical Journal of Gastroenterology   Vol. 7 ( 5 ) page： 387-391   2014.7

A case of gastric carcinosarcoma with distant metastasis for which chemotherapy with S-1 plus cisplatin was transiently effective Reviewed

Osamu Maeda, Takafumi Ando, Kazuhiro Ishiguro, Osamu Watanabe, Ryoji Miyahara, Tomoko Miyata, Keita Itatsu, Yuichi Ando, Hidemi Goto

International Cancer Conference Journal   Vol. 3   page： 252-259   2014.2

DNA hypermethylation in colorectal neoplasms and inflammatory bowel disease: a mini review Reviewed

Osamu Maeda, Takafumi Ando, Osamu Watanabe, Kazuhiro Ishiguro, Naoki Ohmiya, Yasumasa Niwa, Hidemi Goto

Inflammopharmacology   Vol. 14 ( 5-6 ) page： 204-206   2006.12

Scirrhous cancer of the stomach which survived for more than five years after neoadjuvant chemotherapy with UFT (uracil and tegafur) and cisplatin Reviewed

Osamu Maeda, Hiroaki Iwase, Naoto Mamiya, Motosuke Nakamura, Tomokazu Mizuno, Yuji Nishio, Takafumi Ando, Kenji Ina, Kazuo Kusugami

Internal Medicine   Vol. 39   page： 239-244   2000

食道癌の術前化学療法のエビデンス

前田 修

外科   Vol. 85 ( 10 ) page： 1089 - 1094   2023.9

消化管がん薬物療法の進歩

前田修

BIO Clinica   Vol. 38 ( 1 ) page： 26 - 30   2023.1

有害事象(副作用)への対応とケアQ&A　化学療法の有害事象(副作用)、予防と対策

前田修

消化器ナーシング   Vol. 27 ( 12 ) page： 1113 - 1118   2022.12

膵・消化管神経内分泌腫瘍

前田修

腫瘍内科   Vol. 30 ( 5 ) page： 487 - 491   2022.11

外来療法中の悪心・嘔吐,発熱,ポート管理

前田修

臨床消化器内科   Vol. 37 ( 11 ) page： 1439 - 1443   2022.9

食道癌の診療　食道癌に対する集学的治療　周術期補助療法

前田修

臨床消化器内科   Vol. 37 ( 9 ) page： 1149 - 1153   2022.8

非切除悪性肝門部胆管狭窄に対する抗腫瘍療法

前田修、江畑智希

消化器内視鏡   Vol. 34 ( 6 ) page： 1144 - 1149   2022.6

Hepatotoxicity of molecular targgeted therapy

Osamu Maeda, Yuichi Ando

  Vol. 18 ( 5 ) page： 461-466   2016.11

ＤＮＡメチル化と正常大腸 ー特に field cancerization についてー

前田 修, 安藤貴文, 石黒和博, 渡辺修, 日比陽子, 永井拓, 山田清文, 舩坂好平, 宮原良二, 大宮直木, 後藤秀実, Jean-Pierre J.Issa

生物物理化学   Vol. 56   page： 00   2012

緊急を要する重症肝胆膵疾患の診断とその対策　肝臓　特発性細菌性腹膜炎

前田修, 鵜沼直雄

肝・胆・膵   Vol. 33 ( 5 ) page： 667-672   1996.11

視床下部症候群で発症し長期経過観察しえたヒスチオサイトーシスXの１剖検例

前田修，山門実，佐々木憲夫，田中茂，菅原修，高梨利一郎，中尾一和

ホルモンと臨床   Vol. 43 ( 増刊 ) page： 42-45   1995.1

Ca,P,多価イオン代謝異常症 PTH related proteinによる高Ca血症ならびにACTHによる低K血症を呈した肺小細胞癌の1症例

前田修, 杉本徳一郎, 山門実, 他

臨床体液   Vol. 21 ( 1 ) page： 13-16   1994.10

検査値の読み方 特異な皮膚の色をきっかけにヘモクロマトーシスと診断しえた症例

前田修, 鵜沼直雄

臨床消化器内科   Vol. 9 ( 12 ) page： 1929-1934   1994.10

Effects of <i>KRAS</i>, <i>STK11</i>, <i>KEAP1</i>, and <i>TP53</i> mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma

Liang, Y; Maeda, O; Kondo, C; Nishida, K; Ando, Y

PLOS ONE   Vol. 19 ( 7 ) page： e0307580   2024.7

Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer Reviewed

Liang, Y; Maeda, O; Miyata, K; Kanda, M; Sugita, S; Shimizu, D; Nishida, K; Kodera, Y; Ando, Y

CANCER CHEMOTHERAPY AND PHARMACOLOGY   Vol. 93 ( 2 ) page： 121 - 127   2024.2

Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors

Liang, Y; Maeda, O; Ando, Y

JAPANESE JOURNAL OF CLINICAL ONCOLOGY   Vol. 54 ( 4 ) page： 365 - 375   2024.1

Impact of sarcopenia on biliary drainage during neoadjuvant therapy for pancreatic cancer Reviewed

Kataoka, K; Ohno, E; Ishikawa, T; Yamao, K; Mizutani, Y; Iida, T; Takami, H; Maeda, O; Yamaguchi, J; Yokoyama, Y; Ebata, T; Kodera, Y; Kawashima, H

CLINICAL ENDOSCOPY   Vol. 57 ( 1 ) page： 112 - 121   2024.1

Potential drug interactions between pazopanib and proton pump inhibitors/potassium-competitive acid blockers in patients with soft tissue sarcoma Reviewed

Liang, Y; Maeda, O; Shimokata, T; Yokota, K; Koike, H; Sakai, T; Ikuta, K; Urakawa, H; Nishida, Y; Akiyama, M; Ando, Y

INTERNATIONAL CANCER CONFERENCE JOURNAL   Vol. 13 ( 1 ) page： 63 - 67   2024.1

Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA &gt; 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer Reviewed

Nakanishi, K; Tanaka, C; Kanda, M; Miyata, K; Furukawa, K; Maeda, O; Shimizu, D; Sugita, S; Kakushima, N; Furune, S; Kawashima, H; Ando, Y; Ebata, T; Kodera, Y

CANCERS   Vol. 15 ( 21 )   2023.11

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition Reviewed

Mishima, S; Naito, Y; Akagi, K; Hayashi, N; Hirasawa, A; Hishiki, T; Igarashi, A; Ikeda, M; Kadowaki, S; Kajiyama, H; Kato, M; Kenmotsu, H; Kodera, Y; Komine, K; Koyama, T; Maeda, O; Miyachi, M; Nishihara, H; Nishiyama, H; Ohga, S; Okamoto, W; Oki, E; Ono, S; Sanada, M; Sekine, I; Takano, T; Tao, KYK; Terashima, K; Tsuchihara, K; Yatabe, Y; Yoshino, T; Baba, E

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   Vol. 28 ( 10 ) page： 1237 - 1258   2023.10

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors Reviewed

Mishima, S; Naito, Y; Akagi, K; Hayashi, N; Hirasawa, A; Hishiki, T; Igarashi, A; Ikeda, M; Kadowaki, S; Kajiyama, H; Kato, M; Kenmotsu, H; Kodera, Y; Komine, K; Koyama, T; Maeda, O; Miyachi, M; Nishihara, H; Nishiyama, H; Ohga, S; Okamoto, W; Oki, E; Ono, S; Sanada, M; Sekine, I; Takano, T; Tao, KYK; Terashima, K; Tsuchihara, K; Yatabe, Y; Yoshino, T; Baba, E

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   Vol. 28 ( 8 ) page： 941 - 955   2023.8

A feasibility study of modified docetaxel, cisplatin, and capecitabine for advanced gastric cancer followed by gastrectomy Reviewed

Liang, Y; Maeda, O; Miyata, K; Tanaka, C; Kanda, M; Shimizu, D; Fukaya, M; Koike, M; Kodera, Y; Ando, Y

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY     2023.7

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors Reviewed

Naito, Y; Mishima, S; Akagi, K; Hayashi, N; Hirasawa, A; Hishiki, T; Igarashi, A; Ikeda, M; Kadowaki, S; Kajiyama, H; Kato, M; Kenmotsu, H; Kodera, Y; Komine, K; Koyama, T; Maeda, O; Miyachi, M; Nishihara, H; Nishiyama, H; Ohga, S; Okamoto, W; Oki, E; Ono, S; Sanada, M; Sekine, I; Takano, T; Tao, K; Terashima, K; Tsuchihara, K; Yatabe, Y; Yoshino, T; Baba, E

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   Vol. 28 ( 7 ) page： 827 - 840   2023.7

Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis Reviewed

Yamamoto, T; Mizuno, K; Ito, T; Yokoyama, S; Yamamoto, K; Imai, N; Ishizu, Y; Honda, T; Ishikawa, T; Kanamori, A; Yasuda, S; Toyoda, H; Yokota, K; Hase, T; Nishio, N; Maeda, O; Ishii, M; Sone, M; Ando, Y; Akiyama, M; Ishigami, M; Kawashima, H

INVESTIGATIONAL NEW DRUGS   Vol. 41 ( 3 ) page： 512 - 521   2023.6

Feasibility assessment of global standard chemoradiotherapy followed by surgery in patients with esophageal cancer Reviewed

Liang, Y; Maeda, O; Miyata, K; Kanda, M; Shimizu, D; Sugita, S; Okada, T; Ito, J; Kawamura, M; Ishihara, S; Nakatochi, M; Ando, M; Kodera, Y; Ando, Y

MOLECULAR AND CLINICAL ONCOLOGY   Vol. 18 ( 4 ) page： 34   2023.4

Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury

Yamamoto, T; Morooka, H; Ito, T; Ishigami, M; Mizuno, K; Yokoyama, S; Yamamoto, K; Imai, N; Ishizu, Y; Honda, T; Yokota, K; Hase, T; Maeda, O; Hashimoto, N; Ando, Y; Akiyama, M; Kawashima, H

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   Vol. 38 ( 2 ) page： 251 - 258   2023.2

Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases

Maeda, O

NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 85 ( 1 ) page： 33 - 34   2023.2

Preoperative docetaxel, cisplatin, and fluorouracil treatment with pegfilgrastim on day 7 for patients with esophageal cancer: A phase II study

Maeda, O; Fukaya, M; Koike, M; Miyata, K; Kanda, M; Nishida, K; Ando, M; Kodera, Y; Ando, Y

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY   Vol. 18 ( 6 ) page： 578 - 585   2022.12

Results of a Phase II Study on the Use of Neoadjuvant Chemotherapy (FOLFIRINOX or GEM/nab-PTX) for Borderline-resectable Pancreatic Cancer (NUPAT-01)

Yamaguchi, J; Yokoyama, Y; Fujii, T; Yamada, S; Takami, H; Kawashima, H; Ohno, E; Ishikawa, T; Maeda, O; Ogawa, H; Kodera, Y; Nagino, M; Ebata, T

ANNALS OF SURGERY   Vol. 275 ( 6 ) page： 1043 - 1049   2022.6

Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment

Furune, S; Kondo, C; Takano, Y; Shimokata, T; Sugishita, M; Mitsuma, A; Maeda, O; Ando, Y

INTERNATIONAL CANCER CONFERENCE JOURNAL   Vol. 11 ( 1 ) page： 46 - 48   2022.1

Drug-induced thrombocytopenia associated with trastuzumab in a patient with HER2-positive recurrent gastric cancer

Takano, Y; Furune, S; Miyai, Y; Morita, S; Inoue, M; Shimokata, T; Sugishita, M; Mitsuma, A; Maeda, O; Ando, Y

INTERNATIONAL CANCER CONFERENCE JOURNAL   Vol. 11 ( 1 ) page： 67 - 70   2022.1

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial

Kanda, M; Shimizu, D; Miyata, K; Maeda, O; Tanaka, C; Inokawa, Y; Hattori, N; Hayashi, M; Ando, M; Kuwatsuka, Y; Murotani, K; Nakayama, G; Koike, M; Ando, Y; Ebata, T; Kodera, Y

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS   Vol. 24   page： 100853   2021.12

Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival

Yamada, K; Sawada, T; Nakamura, M; Yamamura, T; Maeda, K; Ishikawa, E; Iida, T; Mizutani, Y; Kakushima, N; Ishikawa, T; Furukawa, K; Ohno, E; Honda, T; Kawashima, H; Ishigami, M; Furune, S; Hase, T; Yokota, K; Maeda, O; Hashimoto, N; Akiyama, M; Ando, Y; Fujishiro, M

WORLD JOURNAL OF GASTROENTEROLOGY   Vol. 27 ( 41 ) page： 7190 - 7206   2021.11

Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies

Ito, T; Ishigami, M; Yamamoto, T; Mizuno, K; Yamamoto, K; Imai, N; Ishizu, Y; Honda, T; Kawashima, H; Yasuda, S; Toyoda, H; Yokota, K; Hase, T; Nishio, N; Maeda, O; Kato, M; Hashimoto, N; Hibi, H; Kodera, Y; Sone, M; Ando, Y; Akiyama, M; Shimoyama, Y; Fujishiro, M

HEPATOLOGY INTERNATIONAL   Vol. 15 ( 5 ) page： 1278 - 1287   2021.10

Adjuvant S-1 vs gemcitabine for node-positive perihilar cholangiocarcinoma: A propensity score-adjusted analysis

Takahashi, D; Mizuno, T; Yokoyama, Y; Igami, T; Yamaguchi, J; Onoe, S; Watanabe, N; Maeda, O; Ando, M; Ebata, T

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES   Vol. 28 ( 9 ) page： 716 - 726   2021.9

Correlation Between the Metabolic Conversion of a Capecitabine Metabolite, 5′-Deoxy-5-fluorocytidine, and Creatinine Clearance

Inaishi, T; Fujita, KI; Matsumoto, N; Shimokata, T; Maeda, O; Kikumori, T; Hattori, N; Nakayama, G; Ando, Y

IN VIVO   Vol. 34 ( 6 ) page： 3539 - 3544   2020.11

What is the impact of systemic chemotherapy for lateral lymph nodes in patients with locally advanced low rectal cancer?

Ogura, A; Uehara, K; Aiba, T; Hattori, N; Nakayama, G; Maeda, O; Ando, Y; Kodera, Y; Ebata, T; Nagino, M

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE   Vol. 35 ( 11 ) page： 2073 - 2080   2020.11

Clinical value of serum bone resorption markers for predicting clinical outcomes after use of bone modifying agents in metastatic bone tumors: A prospective cohort study

Urakawa, H; Ando, Y; Hase, T; Kikumori, T; Arai, E; Maeda, O; Mitsuma, A; Sugishita, M; Shimokata, T; Ikuta, K; Ishiguro, N; Nishida, Y

INTERNATIONAL JOURNAL OF CANCER   Vol. 146 ( 12 ) page： 3504 - 3515   2020.6

Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies

Mizuno, K; Ito, T; Ishigami, M; Ishizu, Y; Kuzuya, T; Honda, T; Kawashima, H; Inukai, Y; Toyoda, H; Yokota, K; Hase, T; Maeda, O; Kiyoi, H; Nagino, M; Hibi, H; Kodera, Y; Fujimoto, Y; Sone, M; Gotoh, M; Ando, Y; Akiyama, M; Hasegawa, Y; Fujishiro, M

JOURNAL OF GASTROENTEROLOGY   Vol. 55 ( 6 ) page： 653 - 661   2020.6

Nonexposed wall-inversion surgery as a novel local resection method for neoplasms in the gastrointestinal tract

Fujishiro, M; Furukawa, K; Yamamura, T; Nakamura, M; Honda, T; Maeda, O; Ishigami, M; Kawashima, H

NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 82 ( 2 ) page： 175 - 182   2020.5

Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology

Naito, Y; Mishima, S; Akagi, K; Igarashi, A; Ikeda, M; Okano, S; Kato, S; Takano, T; Tsuchihara, K; Terashima, K; Nishihara, H; Nishiyama, H; Hiyama, E; Hirasawa, A; Hosoi, H; Maeda, O; Yatabe, Y; Okamoto, W; Ono, S; Kajiyama, H; Nagashima, F; Hatanaka, Y; Miyachi, M; Kodera, Y; Yoshino, T; Taniguchi, H

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   Vol. 25 ( 3 ) page： 403 - 417   2020.3

Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition

Mishima, S; Taniguchi, H; Akagi, K; Baba, E; Fujiwara, Y; Hirasawa, A; Ikeda, M; Maeda, O; Muro, K; Nishihara, H; Nishiyama, H; Takano, T; Tsuchihara, K; Yatabe, Y; Kodera, Y; Yoshino, T

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   Vol. 25 ( 2 ) page： 217 - 239   2020.2

Detection of bacteria in blood circulation in patients receiving cancer chemotherapy

Ota, A; Morita, S; Matsuoka, A; Shimokata, T; Maeda, O; Mitsuma, A; Yagi, T; Asahara, T; Ando, Y

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   Vol. 25 ( 1 ) page： 210 - 215   2020.1

Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study

Takano, N; Yamada, S; Hirakawa, A; Yokoyama, Y; Kawashima, H; Maeda, O; Okada, T; Ohno, E; Yamaguchi, J; Ishikawa, T; Sonohara, F; Suenaga, M; Takami, H; Hayashi, M; Niwa, Y; Hirooka, Y; Ito, Y; Naganawa, S; Ando, Y; Nagino, M; Goto, H; Fuji, T; Kodera, Y

NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 81 ( 2 ) page： 233 - 239   2019.5

Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer

Yamada, S; Fujii, T; Yokoyama, Y; Kawashima, H; Maeda, O; Suzuki, K; Okada, T; Ono, E; Yamaguchi, J; Takano, N; Takami, H; Hayashi, M; Niwa, Y; Hirooka, Y; Ito, Y; Naganawa, S; Ando, Y; Nagino, M; Goto, H; Kodera, Y

CANCER CHEMOTHERAPY AND PHARMACOLOGY   Vol. 81 ( 5 ) page： 815 - 821   2018.5

Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in Japan

Morita, S; Kikumori, T; Tsunoda, N; Inaishi, T; Adachi, Y; Ota, A; Shibata, M; Matsuoka, A; Nakanishi, K; Takeuchi, D; Mizutani, T; Shimokata, T; Hayashi, H; Maeda, O; Ando, Y

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   Vol. 23 ( 1 ) page： 195 - 200   2018.2

Lung Metastases from Bile Duct Adenocarcinoma Mimicking Chronic Airway Infection and Causing Diagnostic Difficulty

Sato, M; Okachi, S; Fukihara, J; Shimoyama, Y; Wakahara, K; Sakakibara, T; Hase, T; Onishi, Y; Ogura, Y; Maeda, O; Hasegawa, Y

INTERNAL MEDICINE   Vol. 57 ( 10 ) page： 1429 - 1432   2018

大腸の腫瘍および炎症性疾患におけるＤＮＡメチル化異常

前田修，安藤貴文，後藤秀実

第19回　日本消化器関連学会週間 

DNA hypermethylation and hypomethylation in colorectal cancer

DNA methylation analysis using microarray and its application to diagnostic markers of colorectal cancer

The 69th Annual Meeting of the Japanese Cancer Association 

Analysis of DNA hypermethylation in colon cancer cells using microarray International conference

American Association for Cancer Research 100th Annual Meeting 2009 

DNA hypermethylation in colorectal polyps and inflammatory bowel disease International conference

the 12th International Conference on Ulcer Research 

Beta-catenin potentially acts as a coactivator of GLI1 International conference

The United European Gastroenterology Week (UEGW)